Related references
Note: Only part of the references are listed.Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle
Stephan Glund et al.
DIABETES (2007)
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle
Lubna Al-Khalili et al.
MOLECULAR ENDOCRINOLOGY (2006)
Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line
Jenifer I. Fenton et al.
CARCINOGENESIS (2006)
Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy
F Haddad et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse
KA Mehl et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Differentiation-dependent expression and mitogenic action of interleukin-6 in human colon carcinoma cells: Relevance for tumour progression
W Brozek et al.
EUROPEAN JOURNAL OF CANCER (2005)
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt
C Weigert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice
KA Mehl et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle
JM McClung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
IL-6-induced skeletal muscle atrophy
F Haddad et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting
TW Davis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice
MH Zaki et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats
VR Sopasakis et al.
DIABETOLOGIA (2004)
Skeletal muscle metabolism in physiology and in cancer disease
A Giordano et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Role of NF-κB and cytokine in experimental cancer cachexia
W Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Cytokines in the pathogenesis of cancer cachexia
JM Argilés et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2003)
SOCS3 negatively regulates IL-6 signaling in vivo
BA Croker et al.
NATURE IMMUNOLOGY (2003)
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway
H Steiner et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
In vivo activation of STAT3 signaling in satellite cells and myofibers in regenerating rat skeletal muscles
K Kami et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Exercise, cachexia, and cancer therapy: A molecular rationale
CM Ardies
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2002)
Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen
BE Barton et al.
CYTOKINE (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival
D Duval et al.
FASEB JOURNAL (2000)
Share Paper
